Dr. Mary Lim-Fung, DO
What this data tells you about Dr. Lim-Fung
Dr. Mary Lim-Fung is a cardiovascular disease in Humble, TX, with 13 years in practice. Based on federal Medicare data, Dr. Lim-Fung performed 836 Medicare services across 745 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lim-Fung received a total of $67,812 from 22 pharmaceutical and/or device companies across 1233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lim-Fung is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead | 188 | $11 | $63 |
| Office visit, established patient (30-39 min) | 75 | $87 | $242 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 65 | $10 | $112 |
| Remote pacemaker/defibrillator monitoring, 90 days | 55 | $16 | $68 |
| New patient office visit, complex (60-74 min) | 49 | $168 | $352 |
| Remote pacemaker monitoring, 90 days | 41 | $22 | $72 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 34 | $740 | $3,917 |
| New patient office visit (45-59 min) | 32 | $124 | $289 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 30 | $391 | $1,701 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 30 | $20 | $58 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 30 | $28 | $86 |
| Programming of dual lead pacemaker system | 27 | $60 | $138 |
| Office visit, established patient, complex (40-54 min) | 26 | $139 | $246 |
| Programming of heart rhythm stimulation after drug infusion | 22 | $64 | $412 |
| Initial hospital admission, high complexity | 19 | $139 | $469 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 18 | $239 | $972 |
| Office visit, established patient (20-29 min) | 17 | $71 | $151 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $29 | $139 |
| Insertion of heart rhythm monitor under skin | 14 | $53 | $2,822 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 14 | $131 | $458 |
| Initial hospital admission, moderate complexity | 13 | $104 | $318 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $365 | $1,294 |
| Insertion of implantable defibrillator system | 11 | $704 | $2,773 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for cardiovascular disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lim-Fung is a electrophysiology & remote specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 9%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lim-Fung experienced with electrocardiogram (ekg), 12-lead?
Does Dr. Lim-Fung receive payments from pharmaceutical companies?
How do Dr. Lim-Fung's costs compare to other cardiovascular diseases in Humble?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology